Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
- 3rd side (hint)
The Central Nervous System consists of?
|
Brain & Spinal cord
|
|
|
Peripheral Nervous system is made up of what two types of neurons?
|
efferent & afferent
|
|
|
The Efferent neurons compose what two systems?
|
Autonomic & Somatic
|
|
|
The autonomic nervous system is composed of what two systems?
|
Sympathetic & Parasympathetic
|
|
|
Sympathetic nervous system is also known as?
|
Adrenergic
|
|
|
The Parasympathetic system is also known as?
|
Cholinergic
|
|
|
The neurotransmitter for the adrenergic system is?
|
norepinephrine
|
|
|
Adrenergic receptor cells include?
|
Alpha 1
Alpha 2 Beta 1 Beta 2 Dopamine |
|
|
Drugs that mimic effect of norepinephrine are called?
|
adrenergics
sympathomimetics adrenergic agonists |
|
|
Drugs that block the effects of norepinephrine are called?
|
sympahtolytics
adrenergic blockers adrenergic antagonists |
|
|
Classification of adrenergic drugs:
|
Direct-acting
Indirect-acting Mixed acting |
|
|
Receptor site of adrenergic system include what types?
|
Selective
Non-selective |
|
|
Parasympathetic system is also known as:
|
Cholinergic system
|
|
|
Cholinergic neurotransmitter:
|
Acetylcholine ACh
|
|
|
Cholinergic receptor cells are what types?
|
nicotinic & muscarinic
|
|
|
Drugs that mimic ACh:
|
cholinergic drugs
parasympatheticomimetics cholinergic agonists cholinergic stimulants |
|
|
Drugs that block the effect of ACh:
|
anticholinergics
parasympatheticolytics cholinergic antagonists |
|
|
Classification of cholinergic drugs:
|
Direct-acting
Cholinesterase inhibitors |
|
|
Prototype adrenergic drug:
|
epinephrine
|
|
|
Action and effects of epi
|
Stimulates ALL adrenergic receptors, particularly those of CV and CNS. (non-selective)
|
|
|
Therapeutic uses of epi.
|
Treats shock, cardiac emergencies, asthma, glaucoma & other.
|
|
|
Contraindications of epi:
|
Hypersensitivity, during active labor, closed angle glaucoma, general anesthesia, severe organic cardiac disease, shock states other than anaphalactic.
|
|
|
Side effects of epi:
|
fatigue, sleep disturbances, tremor, weakness, dizziness, cardiovascular stimulation
|
|
|
Nursing implications Epi:
|
Monitor CV status closely.
Schedule doses to minimize sleep disruption & allwo appetite and meals to coincide. |
|
|
Education Epi:
|
Use of inhalers and nebulizers
|
|
|
Prototype nonselective adrenergic agonist:
|
epinephrine (adrenaline)
|
|
|
Alpha 1 agonist prototype:
|
Phenylephrine (Dristan)
|
|
|
Phenylephrine action and effects: (Alpha 1 agonist)
|
Alpha adrenergic agonist and vasopressor (constricts vessels, raises blood pressure)
|
|
|
Phenylephrine (Alpha 1 agonist) therapeutic uses:
|
Treats hypotension, shock related to vascular failure, nasal congestion; also used during anesthesia.
|
|
|
Phenylephrine (Alpha 1 agonist) Contraindications:
|
Hypersensitivity, severe hypertension, ventricular tachycardia and closed-angle glaucoma.
|
|
|
Therapeutic uses of epi.
|
Treats shock, cardiac emergencies, asthma, glaucoma & other.
|
|
|
Contraindications of epi:
|
Hypersensitivity, during active labor, closed angle glaucoma, general anesthesia, severe organic cardiac disease, shock states other than anaphalactic.
|
|
|
Side effects of epi:
|
fatigue, sleep disturbances, tremor, weakness, dizziness, cardiovascular stimulation
|
|
|
Nursing implications Epi:
|
Monitor CV status closely.
Schedule doses to minimize sleep disruption & allwo appetite and meals to coincide. |
|
|
Education Epi:
|
Use of inhalers and nebulizers
|
|
|
Phenylephrine (Alpha 1 agonist) Side affects:
|
hypertension, headache, sleep disturbances. Most serious adverse: reflex bradycardia.
|
|
|
Phenylephrine (Alpha 1 agonist) Nursing Implications:
|
Instill eye drops in conjunctival cul-de-sac. Avoid situations that increase blurred vision.
|
|
|
Phenylephrine (Alpha 1 agonist) Patient Education:
|
Stress safety related to blurred vision.
|
|
|
Alpha 2 agonist prototype:
|
Clonidine (Catapres)
|
|
|
Clonidine (Catapres Alpha-2 agonist) Action and effects:
|
Stimulates alpha-2 receptors centrally, which reduces sympathetic outflow from the CNS and results in decreased heart rate, BP, vasoconstriction, and renal vascular resistance.
|
|
|
Phenylephrine (Alpha 1 agonist) Theraputic uses:
|
Used as a second-line antihypertensive, also to relieve discomfort of withdrawal symptoms from narcotics.
|
|
|
Phenylephrine (Alpha 1 agonist) Contraindications:
|
Hypersensitivity, bleeding disorders, anticoagulants.
|
|
|
Phenylephrine (Alpha 1 agonist) Side Affects:
|
Dry mouth, drowsiness, dizziness, sedation and constipation. Most serious adverse affect: rebound hypertension (with abrupt stopping).
|
|
|
Phenylephrine (Alpha 1 agonist) Nursing Implications:
|
Give clonidine orally in combination with other antihypertensives; apply a new patch to a hairless area every 7 days. Do not stop therapy abruptly.
Be aware of abuse potential. |
|
|
Phenylephrine (Alpha 1 agonist) Patient Education:
|
Teach patient how to manage adverse affects.
|
|
|
Beta agonist prototype:
|
isoproterenol (Isuprel) NON-SELECTIVE
|
|
|
Beta agonist isoproterenol (Isuprel) Action and effects:
|
Relaxes bronchial smooth muscle by stimulating beta-receptors. As a cardiac stimulant, acts on beta-1 receptors in the heart.
|
|
|
Beta agonist isoproterenol (Isuprel) Therapeutic uses:
|
Bronchospasm during anesthesia, heart block, ventricular arrhythmias, shock, postoperative cardiac patients with bradycardia, as an aid in diagnosing the cause of mitral regurgitation, and coronary artery disease or lesions.
|
|
|
Beta agonist isoproterenol (Isuprel) Contraindications:
|
Tachycardia or AV block caused by digoxin intoxications, arrhythmias other than those that may respond to drug, angina pectoris, angle-closure glaucoma.
|
|
|
Beta agonist isoproterenol (Isuprel) Side affects:
|
Headache, mild tremor, weakness, dizziness, nervousness, anxiety.
palpitations, rapid rise and fall in BP, tachcardic arrhythmias, cardiac arrest. nausea, vomiting, hyperglycemia, diaphoresis, swelling of parotid glands with prolonged use. |
|
|
Beta agonist isoproterenol (Isuprel) Nursing Implications:
|
Use of infusion pump. Monitor blood pressure, urinary output, cardiac output and pulmonary wedge pressure throughout therapy.
|
|
|
Beta agonist isoproterenol (Isuprel) Patient Education:
|
Reassure patient that close monitoring will be maintained. Tell patient to report chest pain, fluttering in chest and other adverse reactions.
|
|
|
Alpha angtagonist prototype:
|
Prazosin (Minipres)
|
|
|
Alpha angtagonist Prazosin (Minipres) Action and effects:
|
Vasodilator
|
|
|
Alpha angtagonist Prazosin (Minipres) Therapeutic Uses:
|
Treat refractory CHF, hypertension, Raynaud vasospasm, prostatic obstruction.
|
|
|
Alpha angtagonist Prazosin (Minipres) Contraindications:
|
hypersensitivity
|
|
|
Alpha angtagonist Prazosin (Minipres) Side Affects:
|
Lightheadedness, dizziness, headache, drowsiness, weakness, lethargy, nausea, and palpitations. Most serious: "first dose syncope"
|
|
|
Alpha angtagonist Prazosin (Minipres) Patient Education;
|
Stress safety regarding CNS effects, safe ways to cope with postural hypotension.
|
|
|
Alpha angtagonist Prazosin (Minipres) - Other alpha blockers
|
Daxazosin (Cardura)
Terazosin (Hytrin) Phentolamine (Regitine) Phenoxybenzamine (Dibensyline) |
|
|
Beta Blocker Prototype (beta antagonist):
|
Propranolol (Inderal)
|
|
|
Beta Blocker Propranolol (Inderal) Action and effects;
|
Beta blocker, treats hypertension, angina, cardiac arrhythmias, migraine.
|
|
|
Beta Blocker Propranolol (Inderal): Therapeutic Uses:
|
Decrases heart rate and contractility, slows conduction, suppresses automaticity.
|
|
|
Beta Blocker Propranolol (Inderal): Contraindications:
|
bradycardia, complete heart block, cardiogenic shock, uncompensated cardiac failure, reactive airway diseases, and Raynaud disease.
|
|
|
Beta Blocker Propranolol (Inderal):Side affects:
|
postural hypotension, bronchospasm. MI
|
|
|
Beta Blocker Propranolol (Inderal): Patient Education:
|
Take med exactly as prescribed. Minimize environmental stressors, stress self-monitoring techniques for pulse rate and heartbeat, safe mobility related to postural hypotension, never abruptly stop taking med.
|
|
|
Beta Blocker Propranolol (Inderal): Other Beta Blockers:
|
Atenolol (Tenormin) beta-1 selective
Metoprolol (Lopressor) beta-1 selective Timolol (Blockadren) beta non-selective. |
|
|
Cholinergic Ganglionic stumulating agent:
|
Nicotine
|
|
|
Nicotine Actions and uses:
|
A direct-acting nicotinic agonist used as an adjunct to smoking cessation programs.
|
|
|
Nicotine Contraindications:
|
Immediately post MI, life-threatening dysrhythmias, severe angina.
|
|
|
Nicotine Side affects:
|
erythema, pruritius, burning, headache, insomnia. Most serious: vasculitis
|
|
|
犬
|
Dog
|
quan3
|
|
Nicotine Patient Education:
|
Correct use of multilple administration routes, avoidance of other stimulants.
|
|
|
Cholinergic agonist Cholinesterase inhibitor:
|
Neostigmine (Prostigmin)
|
|
|
Cholinergic agonist Neostigmine (Prostigmin) Actions and effects:
|
An indirect-acting cholinoceptor stimulant used in the management of myasthenia gravis.
|
|
|
Cholinergic agonist Neostigmine (Prostigmin) Contraindications:
|
GI obstruction or ileus, urinary tract obstruction, peritonitis.
|
|
|
Cholinergic agonist Neostigmine (Prostigmin) Side affects:
|
Nausea or vomiting, diarrhea, abd pain, miosis, salivation, diaphoresis, sinus bradycardia. Most serious: cholinergic crisis, cardiac arrest.
|
|
|
Cholinergic agonist Neostigmine (Prostigmin) Nursing implications:
|
Administer at regular intervals to ensure adequate blood levels.
Availability of atropine, the antidote for cholnergic crisis. **Differentiate between cholinergic crisis and myasthenic crisis. |
|
|
Cholinergic agonist Neostigmine (Prostigmin) Patient Education:
|
Symptoms of cholnergic crisis and need for immediate medical attention.
|
|
|
Cholinergic antagonist (blocker) prototype:
|
Atropine Sulfate
|
|
|
Cholinergic antagonist Atropine sulfate Actions and effects:
|
Anticholinergic drug given in evergency situations such as severe bradycardia or during CPR. Used routinely as a preoperative med to reduce intraoperative pulmonary secretions.
|
|
|
Cholinee rgic antagonist Atropine Sulfate Contraindications:
|
hypersensitivity to sulfites, myasthenia gravis, acute MI
|
|
|
Cholinergic antagonist Atropine Sulfate Side Affects:
|
blurred vision, constipation, dry mouth, urinary retention
Most serious: cardiac arrhythmias |
|
|
Cholinergic antagonist Atropine Sulfate Nursing implications:
|
Take med exactly as prescribed and at required dosage, good oral hygene, fluid replacement.
|
|
|
Cholinergic antagonist Atropine Sulfate Patient Education:
|
Safety issues for blurred vision; avoid OTC and herbal medications without the direct approval of the health care provider.
|
|
|
Cholinergic agonist Muscarinic agonist:
|
Bethanechol (Urecholine)
|
|
|
Cholinereimulatgic agonist Muscarinic agonist: Bethanechol (Urecholine) Actions and Uses:
|
Stimulates muscarinic ACH receptors directly, mimics effects of parasymp nervous system stimulation. Stimulates gastric motility, micturition; increases lower esophageal sphincter pressure.
|
|
|
Cholinergic agonist Muscarinic agonist: Bethanechol (Urecholine) Uses:
|
Urinary retention (postop, postpartum)
|
|
|
Cholinergic agonist Muscarinic agonist: Bethanechol (Urecholine) Contraindications:
|
Hypersensitivity, severe bradycardia, asthma, severe hypotension, hyperthyroidism, peptic ulcer, parkinsonism, seizure disorders, CAD, COPD, coronary occlusion, recent urinary or GI surgery.i
|
|
|
Cholinergic agonist Muscarinic agonist: Bethanechol (Urecholine)Nursing Implications:
|
Assess B/P, pulse; observe after parenteral dose for 1 hour. I&O check for urinary retention or urge incontinence. Bradycardia, hypotension, bronchospasm, headache, dizziness, seizures, respiratory depression; product should be discontinued if toxicity occurs.
|
|
|
Cholinergic agonist Muscarinic agonist: Bethanechol (Urecholine) Patient Education:
|
Take exactly as prescribed; 1 hr before or 2 hr after meals. To make position changes slowly; orthstatic hypotension may occur. To avoid driving, hazardous activities until effects are known.
|
|